{"service":"corpus","corpus":"trials","host":"trials.go-v.org","query":"","status":"ok","source":"ClinicalTrials.gov","license":"US NLM public data","citation":"https://clinicaltrials.gov/","caveat":null,"coverage":{"records":612567,"kind":"max_rowid"},"limit":12,"offset":0,"records":[{"id":"NCT07899255","title":"Comparison of TLC (Total Leucocyte Count), Neutrophils and Monocytes in Oral Squamous Cell Carcinoma and Pre-malignant Disorders","text":"Oral Squamous Cell Carcinoma (OSCC); Premalignant Lesion","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07899255","license":"US NLM public data","year":"","url":"/record/NCT07899255","fields":{"status":"ACTIVE_NOT_RECRUITING","phase":"['']","study_type":"OBSERVATIONAL","countries":"Pakistan","sponsor":"Dow University of Health Sciences","start_date":"2026-05-10","completion_date":"2027-07-02"}},{"id":"NCT07929506","title":"Prophylactic CPAP for Late Preterm Infants Born by C-Section to Reduce NICU Admission","text":"Late Preterm Infant","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07929506","license":"US NLM public data","year":"","url":"/record/NCT07929506","fields":{"status":"NOT_YET_RECRUITING","phase":"['NA']","study_type":"INTERVENTIONAL","countries":"Canada;Chile;Spain;United Kingdom;United States","sponsor":"Indiana University","start_date":"2027-01","completion_date":"2029-07"}},{"id":"NCT07912216","title":"Effect of Beeswax-Based Nipple Protector and Breast Milk on Nipple Problems","text":"Breastfeeding; Nipple Pain During Lactation; Cracked Nipple; Cracked Nipple During Lactation","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07912216","license":"US NLM public data","year":"","url":"/record/NCT07912216","fields":{"status":"COMPLETED","phase":"['NA']","study_type":"INTERVENTIONAL","countries":"Turkey (Türkiye)","sponsor":"Marmara University","start_date":"2026-06-23","completion_date":"2026-10-30"}},{"id":"NCT07915609","title":"A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)","text":"Obesity; Overweight and/or Obesity; Knee Osteoarthritis; Diabetes Melliuts, Type 2","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07915609","license":"US NLM public data","year":"","url":"/record/NCT07915609","fields":{"status":"RECRUITING","phase":"['PHASE3']","study_type":"INTERVENTIONAL","countries":"United States","sponsor":"Pfizer","start_date":"2026-10-26","completion_date":"2028-10-30"}},{"id":"NCT07922564","title":"An Open-label, Randomized, Single Oral Dose, Two-period, Two-sequence, Two-way, Crossover Bioequivalence Study on Healthy Adult Male Participants Under Fed Conditions to Compare, Test Product Palbociclib-EVAPHARMA 125 mg Hard Gelatin Capsule, Versus the Reference Product Ibrance™125 mg Capsules","text":"Bioequivalence; Male","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07922564","license":"US NLM public data","year":"","url":"/record/NCT07922564","fields":{"status":"COMPLETED","phase":"['PHASE1']","study_type":"INTERVENTIONAL","countries":"Egypt","sponsor":"Zi Diligence Biocenter","start_date":"2026-02-09","completion_date":"2026-02-19"}},{"id":"NCT07914101","title":"Sequential Chemotherapy Followed by Ultrahypofractionated Radiotherapy for Muscle-Invasive Bladder Cancer","text":"Bladder Cancer; TURBT; Radiotherapy","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07914101","license":"US NLM public data","year":"","url":"/record/NCT07914101","fields":{"status":"NOT_YET_RECRUITING","phase":"['PHASE3']","study_type":"INTERVENTIONAL","countries":"","sponsor":"Assiut University","start_date":"2026-12-01","completion_date":"2027-12-01"}},{"id":"NCT07944651","title":"Pirtobrutinib With Sonrotoclax and Rituximab for High-Risk Relapsed/Refractory Mantle-Cell Lymphoma Following Covalent BTK-Inhibitor Failure","text":"Mantle Cell Lymphoma (MCL); Relapsed/Refractory Mantle Cell Lymphoma (MCL)","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07944651","license":"US NLM public data","year":"","url":"/record/NCT07944651","fields":{"status":"NOT_YET_RECRUITING","phase":"['PHASE2']","study_type":"INTERVENTIONAL","countries":"China","sponsor":"Tianjin Medical University Cancer Institute and Hospital","start_date":"2026-12-08","completion_date":"2030-12-08"}},{"id":"NCT07900451","title":"Multimodal Biomarkers Predicting Medication-Induced Adverse Effects in Children With ADHD","text":"ADHD","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07900451","license":"US NLM public data","year":"","url":"/record/NCT07900451","fields":{"status":"RECRUITING","phase":"['']","study_type":"OBSERVATIONAL","countries":"Taiwan","sponsor":"National Taiwan University Hospital","start_date":"2026-08-01","completion_date":"2029-07-31"}},{"id":"NCT07928622","title":"Inhaled Hydrogen Therapy's Effect on Early Recurrences of Atrial Fibrillation Post-ablation.","text":"Atrial Fibrillation Ablation","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07928622","license":"US NLM public data","year":"","url":"/record/NCT07928622","fields":{"status":"NOT_YET_RECRUITING","phase":"['PHASE2']","study_type":"INTERVENTIONAL","countries":"France","sponsor":"University Hospital, Grenoble","start_date":"2027-01","completion_date":"2029-09"}},{"id":"NCT07914166","title":"Asciminib-Based Induction Therapy for the Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","text":"B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07914166","license":"US NLM public data","year":"","url":"/record/NCT07914166","fields":{"status":"NOT_YET_RECRUITING","phase":"['PHASE1']","study_type":"INTERVENTIONAL","countries":"United States","sponsor":"City of Hope Medical Center","start_date":"2027-10-13","completion_date":"2028-10-13"}},{"id":"NCT07899554","title":"Evaluation of the Role of Serum Tenascin-X Levels in the Diagnosis of Hypermobile Ehlers-Danlos Syndrome","text":"Ehlers-Danlos Syndromes (EDS)","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07899554","license":"US NLM public data","year":"","url":"/record/NCT07899554","fields":{"status":"NOT_YET_RECRUITING","phase":"['NA']","study_type":"INTERVENTIONAL","countries":"","sponsor":"Assistance Publique - Hôpitaux de Paris","start_date":"2026-11-01","completion_date":"2028-03-01"}},{"id":"NCT07944573","title":"AI-Assisted vs. Traditional Simulation for Safe Surgery Checklist Knowledge and Skills","text":"Nursing Education","snippet":"","snippet_marked":"","source":"ClinicalTrials.gov","citation":"https://clinicaltrials.gov/study/NCT07944573","license":"US NLM public data","year":"","url":"/record/NCT07944573","fields":{"status":"NOT_YET_RECRUITING","phase":"['NA']","study_type":"INTERVENTIONAL","countries":"Turkey (Türkiye)","sponsor":"Lokman Hekim University","start_date":"2027-10-01","completion_date":"2029-04-15"}}],"generated_at":"2026-11-22T19:43:30Z"}